iolcp presentation

IOL Chemicals and Pharmaceuticals Limited

Geographical Location Map

Barnala

Mile Stones Crossed

• 1986 – IOLCP Established

• 1991 – Commenced Acetic Acid Production

• 1996 – Commissioned Ethyl Acetate Plant

• 1999 – Commenced Acetic Anhydride Production • 2000 – Commissioned Ibuprofen Plant

• 2006 – Commissioned Power Cogeneration

Product RangeActive Pharmaceutical Ingredients Ibuprofen Proton Pump Inhibitors (PPI’s) (Proposed)

Chemical Products

Acetic Acid Ethyl Acetate Acetic Anhydride MCA & Acetyl Chloride IBB

Capacity By Product

Products

0

1000

2000

3000

4000

Ibuprofen

0

10000

20000

30000

40000

50000

60000

70000

80000

Acetic Acid

Ethyl Acetate

Acetic Anhydride

Ca

pa

city

( T

PA

)

Revenues

97

174

232

361334

0

50

100

150

200

250

300

350

400

450R

s in

Cro

res

2004-05 2005-06 2006-07 2007-08 2008-09USD 48 mlnUSD 36 mlnUSD 20 mln USD 75 mln

Years

USD 70 mln

Operating Profit

9

18 19

3735

0

5

10

15

20

25

30

35

40

Rs

in C

rore

s

2004-05 2005-06 2006-07 2007-08 2008-09

USD 1.8 mln USD 7.7 mlnUSD 3.9 mlnUSD 3.8mln

Years

USD 7.2 mln

Net Profit After Tax

2.55

7.26 7.55

12.3612.69

0

2

4

6

8

10

12

14R

s in

Cro

res

2004-05 2005-06 2006-07 2007-08 2008-09

USD 0.53 mln USD 2.57 mlnUSD 1.57 mlnUSD 1.51 mln

Years

USD 2.64 mln

Revenue Distribution By Product (%)

0

5

10

15

20

25

30

35

40

45

Ibuprofen Acetic Acid Ethyl Acetate AceticAnhydride

% T

urn

ove

r

Products

Export Sales

2

13

23

50

44

0

5

10

15

20

25

30

35

40

45

50

55R

s i

n C

rore

s

2004-05 2005-06 2006-07 2007-08 2008-09

USD 0.41 mln USD 10.4 minUSD 4.79 minUSD 2.70mln

Years

USD 9.16mln

GROWTH - Projects Under Implementation

• Recently increased Ibuprofen capacity from 1800 TPA to 3600 TPA .

• Currently implementing projects for Capacity Expansions, Forward & Backward Integration & Power Cogeneration, involving a capital expenditure of Rs 256 Crores (approx USD 53.3 million).

• Commencing a new project for the production of PPI’s i.e. Rabiprazole, Omeprazole, Pantoprazole Esomeprazole and Lansoprazole in Jan 2010 at a cost of Rs 100 Crores ( approx USD 20.83 million).

Under Implementation Projects Contd…

Product UOMExisting

CapacitiesProposed Capacities

Expected Completion

Date

Capacity Enhancement

Acetic Acid TPA 50000 75000 Nov,2009

Acetic Anhydride TPA 12000 18000 Nov,2009

Ethyl Acetate TPA 33000 36000 Nov,2009

Ibuprofen TPA 3600 6000 Dec., 2009

Cogeneration MW 4 17 Nov,2009

Backward Integration

Iso Butyl Benzene(Used as RM For Ibuprofen) TPA - 6600 Nov,2009

Forward Integration

Monochloroacetic Acid

Acetyl ChlorideAcetic Anhydride as RM End use in Ibuprofen

TPA - 7200 Nov,2009

TPA - 5200Nov,2009

Upcoming Projects

PPI’s TPA - 480 March , 2011

Co-generation

Expanding captive power cogeneration

capacity to 17 MW, from 4 MW currently

Present captive energy generation include

Steam and Power Generation

Acetic Anhydride

Acetic Acid

HCl

Acetyl Chloride MCA

Chlorine GasAcetic Acid (By Product)

HCl (By Product)

Monochloroacetic Acid & Acetyl ChlorideProcess Flow

Uses of Iso-Butyl Benzene

IBB PLANT

IBB SPENT GAS HIGH HYDRO

CARBON

POTASIUM CARBONATE

LOW HYDRO

CARBON

CAPTIVE CONSUMP TION

MARKET ACETIC

ANHY

DRIDE

THERMO

PACK

CO-

GEN

ACETIC

ANHY

DRIDE

THERMO

PACK

CO-

GEN

ACETIC

ANHY

DRIDE

MARKET THE END PACK

MARKET REUSE IN IBB PROCESS

Projected Capacity Fiscal Year 2011-12

Product UOMThen

CapacitiesPotential

Capacities

Capacity Enhancement

Acetic Anhydride TPA 18000 33000

Ethyl Acetate TPA 36000 50000

Ibuprofen TPA 6000 8000

Iso Butyl Benzene TPA 6600 10000

Monochloroacetic Acid TPA 7200 10000

Acetyl chloride TPA 5200 8000

ALL OF THESE PROJECTS WILL HAVE TO BE FINANCED FROM INTERNAL ACCRUALS AND TERM DEBT WITHOUT FURTHER DILUTION IN EQUITY. THIS WILL RESULT IN SIGNIFICANT GROWTH IN PROFITABILITY AND EARNINGS PER SHARE

Global Market PresenceThe various international markets catered till date

include:

1.BANGLADESH 15.IRAN 29.SPAIN 43.ITALY

2.EGYPT 16.VEITNAM 30.PHILIPPINES 44.MAURITIUS

3.UGANDA 17.KUWAIT 31.CHILE 45.CHILE

4.SYRIA 18.GERMAN 32.ZIMBABWE 46.TAIWAN

5.AUSTRALIA 19.COLOMBIA 33.URUGUAY 47.TASMANIA

6.DUBAI 20.SINGAPORE 34.GHANA 48.OMAN

7.PAKISTAN 21.HONG KONG 35.TURKEY 49.COLOMBIA

8.THAILAND 22.MALAWI 36.CHINA 50.SOUTH AMERICA

9.MALAYSIA 23.BRAZIL 37.CONGO 51.YEMEN

10.BOLIVIA 24.SOUTH KOREA 38.SUDAN

11.MEXICO 25.PERU 39.NIGERIA

12.VENEZUELA 26.GUATEMALA 40.KENYA

13.ALGERIA 27.NEPAL 41.NEW ZEALAND

14.LATAVIA 28.DENMARK 42.SRI LANKA

Our Products - Our Pride

Ibuprofen• Non-Steroidal Anti – Inflammatory Drug (NSAID)

• Reduces Hormones Causing Inflammation & Pain in Body

• Usage in Treatment of Variety of Ailments

• Grades Available :

- IP / BP /USP / EP /JP- Micronized

- Dexibuprofen - DC ( Directly compressible )

Applications & End Usage - Ibuprofen

Application End Use User

Pharma Industry as an NSAID ( Non- steroidal Anti -

inflammatory Drug )

InflammationAristo Pharmaceuticals

Ltd

Acute / Chronic Pains Sri Krishna

Pharmaceuticals Ltd

Rheumatoid Pain Tablets India Limited

Primary Dysmenorrhea Indoco Remedies Limited

Post Operative Pain Fourrts Lab Limited

Fever Strides Arcolabs ltd


Pharma Industry as an NSAID ( Non- steroidal Anti -

inflammatory Drug )

InflammationAristo Pharmaceuticals

Ltd

Acute / Chronic Pains Sri Krishna

Pharmaceuticals Ltd

Rheumatoid Pain Tablets India Limited

Primary Dysmenorrhea Indoco Remedies Limited

Post Operative Pain Fourrts Lab Limited

Fever Strides Arcolabs ltd

Indian Scenario - Ibuprofen

0

1000

2000

3000

4000

5000

6000

7000

8000

9000

10000

Cap

acit

y (I

n M

T)

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION (MT)

CONSUMPTION (MT)

EXPORT FROM INDIA

Global Production – Ibuprofen

0

5000

10000

15000

20000

25000

30000

In M

T

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION (MT)

Ibuprofen Production Capacities - IOLCP

600 720

1800

3600

6000

0

1000

2000

3000

4000

5000

6000

7000

8000P

rod

uc

tio

n (

TP

A)

2000-01 2005-06 2006-07 2007-08 2009-10

Year

Ibuprofen - Market Share

Shasun48%

Satwik3%

Others7%

Satyadeeptha5%

IOLCP37%

BASF, UK20%

Hubei,China13%

Others15%

Albemarle, USA 17%

Shasun,India 16%

IOLCP13%

Zhongtianhengdi,China

7%

Domestic Market Global Market

Indian Market 8000 MT per Annum

Global Market 25,000 MT per Annum

• Acetic Acid or Ethanoic Acid Commonly Known as Vinegar

• Sour Taste & Pungent Smell

• Widely used as Chemical Reagent & Industrial Chemical

• Derivatives application almost in all fields

Acetic Acid

Applications & End Usage –Acetic AcidApplication End use User

As in preparation of Pharmaceuticals

Eg. In the preparation of Sulphamethoxazole, Chloroquin,

Metronidazole etc.

IPCA, CADILA ,SR Drugs & Intermediates Ltd,Avon

Organics Ltd

As in Polyester Staple Fiber industries

In making Purified telepthalic acid (PTA)

Reliance , Indian Oil , Mitsubishi Chemical

Corporation

As Acidulant & Preservative

Eg: Vinegar, Jams, Pickles, Ketchups etc

Cremica , Nestle ,Bonn industries ltd,

As in preparation of Acetates

Eg. Cellulose acetate, Ethyl Acetate, Zinc acetate, Amyl acetate etc

IOLCP, Ester India ltd, Shatabdi Chem. Pvt Ltd, Kashyap Organics Ltd

As a Chemical synthesize solvent

For e.g. Monochloroacetic acid (MCA) *, Vinyl Acetate Monomer

(VAM)

Farmson, Swati, Reliance Cellulose products Ltd,S.R.Drugs and

Intermediates (P) Ltd,Sree Rayalaseema Hi-Strength

Hypo Ltd,Karnavati Chemical

*IOLCP is Entering into the Manufacturing of MCA with the Capacity of 7200 TPA.

Application End use User

As an intermediate in Pesticides

Eg. Chlorpyriphos, Acephate

Aimco Pesticides Ltd,Bharat Rasayan Ltd,Meghmani

Organics Ltd,Rallis India Ltd, Gujarat Ltd,United Phosphorous Ltd

Diketene & its derivatives

Eg. Monomethyl acetoacetamide, ethyl acetoacetamide, Methylaceto

Acetate

Colourchem Ltd.,Mumbai ,Indian Dyestuff

Industries,Gujarat ,Avon Organics Ltd., Hyderabad

As Tanning agent Laundry sour, printing calico &

dyeingNahar spinning , Vardhman ,

JCT

As Reaction Solvents For gums, resins & volatile oilsTurpentine and Oil Co, Camphor and allied Co

Applications & End Usage- Acetic Acid

0

100000

200000

300000

400000

500000

600000

700000

Cap

acit

y (

In M

T)

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION (MT)

CONSUMPTION (MT)

Indian Scenario – Acetic Acid

Global Production – Acetic Acid

0

1000000

2000000

3000000

4000000

5000000

6000000

7000000

8000000

9000000

10000000

Cap

acit

y (

In M

T)

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION(MT)

Acetic Acid Production Capacities - IOLCP

45007500

1350018000

30000

50000

75000

-5000

5000

15000

25000

35000

45000

55000

65000

75000

85000P

rod

uct

ion

(T

PA

)

1991-92 1997-98 1998-99 2004-05 2005-06 2006-07 2008-09

Year

Captive Consumption Vs Merchant Sales –Acetic Acid

0

10

20

30

40

50

60

70

80

90

100

Qu

anti

ty P

erce

nta

ge

2004-05 2005-06 2006-07 2007-08 2008-09

Years

Captive Consumption

Merchant Sales


Acetic Acid – Market Share

GNFC39%

IOLCP13%

Jubilant28%

Others 7%JR Agro

6%Somaiya

7%

Celanese24%

BP Aramco23%

Millennium 4%Diacel 4%Eastman3%

Wujing 4.4%

Azot 3%

Indian Market 4,50,000 MT per Annum

Global Market92,00,000 MT per Annum

• Ethyl Acetate or Ethyl Ethanoate – Fragrant, Colorless Liquid

• Diverse Industrial Application as Solvent

• Usage as Synthetic Fruit Essence

• Flavor in Pharmaceuticals

• Coextractant of Camphor, Fats, Oils & Antibiotics

• Ability to replace Aromatic Solvents like Toulene, Xylene & Methyl Isobutyl Ketone.

Ethyl Acetate


As Lacquer sandling sealer, Glasswood lacquer, Lacquer

thinner, LP inks, quickset inks, heatset & coldset inks etc

Inks & Paints Industry

Berger Paints India, Goodlac Nerolac Paints Ltd, Resins &

Solvents,Camlin Ink Pvt Ltd,Kores India

As a media Solvent / wraper shining and protection

Flexible Packaging & lamination

Uflex Ltd , Dharmapal Satyapal industries , PG foil Ltd ,Cosmo films

ltd,Essel packaging

For production of Glues etc. AdhesivesConverter & Adhesives Chemicals

Ltd

In PharmaceuticalRantidine HCL

Sulphamethoxazole etc

IPCA, CADILA ,SR Drugs & Intermediates Ltd,Avon Organics

Ltd,Shasun

For creating lustre in photgraphic films to last long

Photographic Films & Plates

Kodak

Solvents for nitrocellulose lacquers , varnishes and

thinners.Least toxic of organic solvents

Surface coatings and thinners

Godrej,Schenectedy,Bakelite Hylam

Extensively used in the preparation of synthetic fruit essences,

flavours and perfumes

Flavours and essences

Privi Organics, Vadilal Industries Ltd , Narula foods

Applications & End Usage – Ethyl Acetate

0

50000

100000

150000

200000

250000

300000

Cap

acit

y (I

n M

T)

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION (MT)

CONSUMPTION (MT)

Indian Scenario- Ethyl Acetate

0

500000

1000000

1500000

2000000

2500000

Cap

acit

y (

In M

T)

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION (MT)

Global Production- Ethyl Acetate

Ethyl Acetate Production Capacities - IOLCP

30005100 6300

18000

3300036000

0

5000

10000

15000

20000

25000

30000

35000

40000P

rod

uct

ion

(T

PA

)

1996-97 2000-01 2004-05 2005-06 2006-07 2008-09

Year


Ethyl Acetate - Market Share

Jubiliant41%

IOLCP16%

Laxmi Organics

15%

Somaiya8%

JR Agro5%

Dhampur4%

Others 11%

BP Aramco13%

Celanese12%

Showa Denko 9%

Rhodia Brazil6%

Shandang6%

Others54%

Indian Market 1,90,000 MT per Annum


• Ethanoic Anhydride or Acid Anhydride

• Declared As “Controlled Substance” under the Narcotics Drugs & Psychotropic Substances (NDPS) Act 1985 by Narcotics Control Bureau, India

• Usage in Pharmaceutical, Agrochemical, Dyes & Pigments, Cellulose Acetate Production

Acetic Anhydride


Drugs & Pharmaceuticals

Eg. In the making of Paracetamol, Aspirin,

Caffeine, Theophylline, Ephedrine HCl

Sri Krishna Pharmaceuticals Ltd ,Triton Laboratories Ltd, Ltd,Granules India ,

Kudos Chemie

Agrochemicals E.g. AcephateAimco Pesticides Ltd,Bharat Rasayan

Ltd,Meghmani Organics Ltd,Rallis India Ltd, United Phosphorous Ltd

Perfume Industry E.g. AcetanilideMaschmejir Aromatics (India)

Ltd ,Hindustan Polyamide,Camphor & Allied Products, Gujarat

As an reactive agent

E.g. Vinyl Acetate Monomer

Jubliant Organysys Ltd, Vinyl Chemicals Ltd

Dyestuff & Intermediaries

E.g. Acetyl Chloride*

Gujarat Industrial Chemicals Corporation, Gwalior Chemical Industries Ltd, Indu

Organic Chemicals, Amarjas Chemicals, Praveen Organics

Applications & End Usage-Acetic Anhydride

*IOLCP is installing the Manufacturing Plant of Acetyl Chloride with the Capacity of 5200 TPA.

0

10000

20000

30000

40000

50000

60000

70000

80000

Cap

acit

y (

In M

T)

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION (MT)

CONSUMPTION (MT)

Indian Scenario-Acetic Anhydride

0

50000

100000

150000

200000

250000

300000

Cap

acit

y (

In M

T)

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION (MT)

Global Production- Acetic Anhydride

Acetic Anhydride Production Capacities - IOLCP

4500

7500

12000

18000

0

2000

4000

6000

8000

10000

12000

14000

16000

18000

20000P

rod

uc

tio

n (

TP

A)

1998-99 2005-06 2006-07 2008-09

Years


Acetic Anhydride - Market Share

Jubiliant47%

IOLCP27%

Luna23%

Dhampur2%

Eastman33%

Celanese24%

Jilin 5%Rhodia 5%

Accordis 5%

BP Aramco10%

Diacel11%

Indian Market55,000 MT per Annum


Upcoming ProjectsMCA & Acetyl Chloride

1. Producing MCA without using hydrogenation.2. MCA Plant is equipped with bubble cap graphite distillation Column instead of packed column.3. Plant is equipped with Scrubbing System to take care of Environment Aspects.4. In the Plant 900 critical parameters controlled by DCS for maintaining product quality and quantity

Contd..

5.Plant is based on forward and backward integration of existing products.

6.Acetyl Chloride is manufactured with HCL root instead of other root to reduce its cost and byproduct.

7.Process Parameters are designed using Simulation Software “CHEMCAD” Supplied by Chemstations USA.

8.Equipped with Teflon coated pipe and fitting to minimize maintenance problem.

Iso Butyl Benzene1.IBB Plant is equipped with Pneumatic transfer System instead of pumps to save power.2.In the Plant 1400 Critical parameters controlled by DCS to maintain product quality and Yield.3.In the Plant Air Compressors are equipped with Variable Frequency to get Energy Efficiency.4. IBB Plant is the Backward integration of existing product of IOLCP.

Manufacturing & Consumption (India) ( MCA, IBB, Acetyl Chloride )

0

20000

40000

60000

80000

100000

120000

MCA IBB Acetyl Chloride

Products

Cap

acit

y (T

PA

)

Manufacuters

Consumption

Manufacturer's in India…MCA Acetyl Chloride IBB

S.R Drugs and Intermediates Ltd

Excel Industeries Limited Vinati Organics

Reliance Cellulose Aqua Pharma SI Group

Meridian Chem-Bond Ltd

Gwalior Chemicals India Ltd

Anugrah In-Org ( P ) Ltd

Sanghvi Organics Pvt Ltd

Kanrnavati Seem Products

A.V.OrganosysRencal Chemicals India Ltd

Abhishek ImpexMisc-Others

Deedy Chem

Maruti Organics

ACI Ind

Swati Chemicals

Upcoming Diversification PlansAnti-ulcerants-

Proton Pump Inhibitors (PPI’s)• The company has planned for installation of new

manufacturing facilities of PPIs- i.e. Rabiprazole, Omeprazole, Esomeprazole, Lansoprazole & Pantoprazole .

• Rabiprazole is used to treat conditions where the stomach produces too much acid, including ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome.

• The total amount of Capital Expenditure will be about Rs 100 Crores ( approx USD 20.83 million).

• The Project of Rabiprazole is planned to be implemented from 2009-10.

• Bind to Proton Pump and Prevent it from Producing Acid in to the Stomach.

• Usage in Treatment of Variety of Gastric Ailments.

• Generally have More Potent Effect on Suppressing Acid than H-2 Blockers ( like Ranitidine, Cimetidine, Nizatidine ).

• PPI’s Available : - Rabeprazole - Lansoprazole- Omeprazole- Pantoprazole- Esomeprazole

Proton Pump Inhibitors (PPIs)

Comparison of PPIs and Antacids

PPIs: ANTACIDS:

Prevent Secretion of Gastric Acid by Inhibiting Proton Pump in Stomach.

Neutralize Gastric Acid. e.g. Aluminium Hydroxide & Magnesium Hydroxide.

Their Onset of Action is comparatively late but have comparatively very Long Duration of Action.

They Provide Faster Relief from Heartburn but have very Brief Duration of Action.

Work in Gastric Lumen. So Useful in Almost All Gastric Ailments.

Work almost in Esophageal Lumen which Limits its Use only for Spontaneous Relief from Heartburn.

Very Low Rate of Recurrence of Disease.

Rate of Recurrence of Disease is Higher.

Ref: www.medscape.com/viewarticle/464898

Comparison of PPIs and H-2 BlockersPPIs: H-2 Blockers:

Prevent Secretion of Gastric Acid by Inhibiting Proton Pump in stomach.

Prevent or Block Histamine from Stimulating the Production of Acid. e.g. Cimetidine, Famotidine, Nizatidine & Ranitidine.

Works at the Site where Acid is being made. That’s why More Effective in Suppressing Gastric Acid secretion

Works at the Site which Stimulates the Production of Gastric Acid.

Longer Duration of Action, more than 24 hrs.

Duration of Action is 2-3 hrs

Comparatively More Efficacious in Treatment of GERD, Gastric Ulcers and Healing of Erosive Esophagitis

Comparatively Less Efficacious in Treatment of GERD, Gastric Ulcers and Healing of Erosive Esophagitis.

Dose is 20 mg / day. Usual Dose is 300 mg / day, but Long Term 150 mg / day

1.Am J Gastroenterol. 2000 Apr;95(4):936-42; 2. Dig Dis Sci. 2001 Mar;46(3):587-963. ISSN 1007-9327 CN 14-1219/R World J Gastroenterol 2005 July 14;11(26):4067-4077

Applications & End Usage- PPIs


Pharma Industry as an ANTI- ULCER Drug

Dyspepsia Dr Reddys Lab.

Peptic ulcer Disease Cipla

GERD / GORD Mankind

Zollinger - Ellison Syndrome Lupin Labs.

Gastrinomas Aurobindo Pharma

Barrett’s Syndrome Nicholas

0

200

400

600

800

1000

1200

1400

1600

1800

Cap

acit

y (I

n M

T)

2005-06 2006-07 2007-08 2008-09 2009-10

Years

PRODUCTION (MT)

CONSUMPTION (MT)

Indian Scenario of PPIs

0

2000

4000

6000

8000

10000

12000

14000

2005-06 2006-07 2007-08 2008-09 2009-10

Production

Global Scenario of PPIs

Years

Cap

acit

y In

MT

Growth Potential

• Potential for growth of these products is demonstrated by their growing usage in various industries.

• While the demand growth is being accompanied by an increase in production capacities, there is still a significant projected demand – supply gap for these products in the market.

• Ethanol, major raw material, available in abundance from Distilleries of Punjab & UP.

• Company’s markets for these products are being significantly enhanced with the commencement of Indian Oil’s Refinery nearby at Panipat & from another upcoming HPCL-Mittal Refinery nearby at Bhatinda

Organisation ChartChairman cum

Managing DirectorVarinder Gupta

Executive Director

R K Thukral

Vice PresidentFinance &Accounts

Rakesh Mahajan

Sr. CompanySecretary

Krishan Singla

Vice PresidentCommercialN K Pundir

Vice PresidentPurchase J K Bajaj

Vice PresidentProductionChemicals

Damandeep Singh

Vice PresidentProduction

PharmaceuticalsVijay Singla

Vice PresidentCo-GenerationTripinder Singh

Vice PresidentR&D

Quality ControlRavi Sharma

Sr. ManagerUtilities

Deepak Saini

Sr. ManagerHRM

Anil Kathuria

ManagerElectrical

Gaurav Bannerjee

ManagerDomestic SalesChetan Asthana

ManagerExport Sales Ravi Mahant

ManagerPurchase

Himanshu Arya

ManagerProject

Rohit Sharma

ManagerFinance

Ajay Latawa

ManagerAccounts

Pardeep Khanna

CompanySecretary

Sushil Sharma

ManagerInstrumentation

Gopal Singla

Manager LegalGurinder Singh

Manpower

0%

20%

40%

60%

80%

100%

Acc &

Fin

ance

Comm

erci

al

HRM

Product

ion

Simula

tion

Quality

& R

&D

Professionals

Post Graduate

Graduate

Diploma & Others

Recognition

Awarded with “2nd National Energy Conservation Award”

Consecutively for the Years 2005, 2006,2007 & 2008

By Ministry of Power, Government of India

Commitment to Quality

• The Company is committed to utilizing state-of-the- art and globally competitive technology in its manufacturing and processing facilities.

• High Quality Products with Quality Checks at each and every stage, starting from Raw Material to Finished products with latest Technology Instruments.

Certifications

• Certificate of Pharmaceuticals Product-WHO for Ibuprofen.

• Certificate of Foreign Drug Manufacturer from Japan. • Koshar Certificate for all finished products

• Halal Committee Registration Certificate for Finished products

• ISO 9001:2008 for Quality Management System • ISO 14001:2004 for Environmental Management System

• Certificate for Foreign Trade Policy-STAR EXPORT HOUSE

Corporate Ethics

The company believes that adherence to the corporate ethics and transparent working results in substantial and sustainable improvements in the performance. The Company has adopted the following practices :

• Code of Corporate Governance & Conduct• Code to Prevent the Insider Trading• Code of Corporate Disclosure of Insider Trading • Whistle Blower Policy

Process Automation Distribution Control Based

Operations-Complete Automation of Process

- Computerized Parameter recording

- Better control of Process Parameters

- Operations on single mouse click

REACTION

DISTILLATION

SEPARATION

Our Technical Specializations

Research & Development

Equipped with latest infrastructure

Highly competent research team

Manufacturing technology for all the products

developed in-house

Capacity to produce single to multi-kilogram

quantities of organic compounds

Pilot plant studies for new products /

molecules

ChemCAD (Simulation Software)

Energy Saving Measures

• Energy Conservation - Major Emphasis Area

• The most cost effective way for sustainable energy development is by improving end-use efficiency.

• We Utilize Waste Process Energy to produce 660 TR/Day of Chilled Water generated through VAM Machines.

Environment Friendly Plant

Untreated Effluent Treated Effluent Standard

pH 4.0 - 5.0 7.0 – 8.0 7.0 - 8.0

TDS (mg/L) 2100 - 2500 1600 - 1800 <2100

BOD (mg/L) 10000 - 12000 20 - 30 < 30

COD (mg/L) 14000 - 18000 175 - 200 < 250

Contact Us

Head Office 85 , Industrial Area ‘A’ Ludhiana- 141003 India

Tele +91-161-2225531-35 Fax +91-161-2608784 , 2226929

Works: Village Fatehgarh Channa Mansa Road Barnala-148101

Tele +91-1679-285285-88Fax +91-1679-285292

Contact Persons Mr Varinder Gupta [email protected]

Mr. Rakesh Mahajan

[email protected]

Mr. R.K.Thukral [email protected]

Website : www.iolcp.com

iolcp presentation

Documents